Applied Cells is thrilled to announce the opening of the CellQuestGrant.
From Applied CellsOct 2 2023Reviewed by Lily Ramsey, LLM Applied Cells is thrilled to announce the opening of the CellQuest Grant call to all clinical research scientists with a special interest in multiple myeloma and cell therapy development applications. This remarkable initiative, available until mid-November 2023, offers the opportunity to win a six-month placement of the company’s propriety MARS® Bar cell separation instrument, along with necessary reagents, training and assistance.
The collaborative program aims to support exceptional research projects with top-of-the-range cell separation technologies, helping to accelerate our understanding of multiple myeloma and propel the fight against the disease.This exciting award package offers unparalleled access to the company’s proprietary MARS Bar platform, which uses automated immunomagnetic separation to enrich target cells with high recovery, high purity and high reproducibility.
The prize includes a six-month placement of the MARS Bar instrument, supply of cell isolation reagents and consumables, comprehensive training, application development support, and ongoing assistance from a dedicated application scientist. Applied Cells is excited to invite researchers from around the globe to submit proposals that align with four distinct research areas.
Applicants can learn more and apply at https://appliedcells.com/grant-2023/.Researchers interested in finding out more can connect with Liping Yu, Vice President of Applications at Applied Cells, at the 20th IMS Annual Meeting, September 27-30, to discuss this incredible grant opportunity. Click here to book a meeting with Liping or schedule a call with an Applied Cells representative today.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Fuel Cells Are Key To America’s Energy IndependenceFuel cells offer a solution to America's electric grid reliability issues, providing on-site power, environmental benefits, and enhanced national security.
Read more »
Pokémon Go October Field Research tasks and their rewards explainedAll October Field Research tasks in Pokémon Go explained, plus how Special Research and Research Breakthrough rewards w…
Read more »
Making immunotherapy safe for AMLAcute myeloid leukemia (AML), the second most common leukemia in children, is hard to treat and has a five-year survival rate of just 65 to 70%, according to the American Cancer Society. While immunotherapies like monoclonal antibodies or CAR T-cell therapy are effective for certain blood cancers, they have not been possible in AML because of toxicity concerns. It's been hard to find targets on leukemia cells that normal blood stem cells don't share, so immunotherapy runs the risk of harming normal cells.
Read more »
Breakthrough Research Revolutionizes Hydrogen GenerationA research team from City University of Hong Kong has developed a groundbreaking electrocatalyst that significantly enhances hydrogen production through electrochemical water splitting.
Read more »
Food insecurity doubles rate of severe hypoglycemia in adults with diabetes, research showsResearch presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2–6 Oct) has found that severe hypoglycemia is more than twice as common among adults with diabetes who struggle to afford food.
Read more »